Researchers have reported that patients given a specific combination of new blood pressure drugs are one-third less likely to develop diabetes than those on older pills.
Read More »Diabetes In Control
Diabetes Drug Shows Promise In Treating Alzheimer’s
Treatment of high blood sugar may have a scientific connection to memory loss that could, one day, benefit millions of people with Alzheimer’s Disease, which affects up to 4.5 million older Americans, bringing with it impaired thinking and memory.
Read More »Pomegranate Juice Could Benefit Diabetics
Technion-Israel Institute of Technology researchers say that pomegranate juice may provide important health benefits for diabetic patients. According to results published in the August 2006 issue of Atherosclerosis, subjects who drank 180 ml (6 oz.) of pomegranate juice per day for three months experienced a reduced risk for atherosclerosis, a …
Read More »Chronically High Blood Sugar Linked To Risk Of Cognitive Impairment
A four-year study of elderly women has found that chronically elevated blood sugar is associated with an increased risk of developing either mild cognitive impairment (MCI) or dementia.
Read More »With Few Factors, Adult Cells Take On Character Of Embryonic Stem Cells
With the introduction of just four factors, researchers have successfully induced differentiated cells taken from embryos to behave like embryonic stem cells. The researchers reported their findings in an immediate early publication of the journal Cell, published by Cell Press.
Read More »High Blood Glucose Stimulates Glucagon Secretion
While glucagon secretion is normally triggered by hypoglycemia and inhibited as glucose levels rises, it has now been shown that very high glucose levels paradoxically stimulate glucagon secretion
Read More »New Breakthrough In Fight To Combat Diabetes
Researchers have made a breakthrough which could eventually help prevent people developing diabetes.
Read More »Symlin® Improved Control in Patients With Type 2 Diabetes on Established Regimen
Amylin Pharmaceuticals, announced positive results from a recent 16-week study evaluating the safety and efficacy of adding SYMLIN®) (pramlintide acetate) to an established regimen of basal insulin glargine (with or without oral antidiabetic agents) in patients with type 2 diabetes who have not progressed to mealtime insulin therapy.
Read More »Lowering Blood Pressure: Take a Hike!
Three or four short, brisk walks throughout the day can be more helpful to people watching their blood pressure than one continuous bout of exercise, Indiana University researchers report.
Read More »Fasting Glucose Levels Related to Exercise Capacity
Patients with diabetes and elevated fasting blood sugars have less capacity to exercise.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.